Form 4: Twist Bioscience Corp Executive Sells Shares to Cover Tax Obligations

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 162 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On May 5, 2025, Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp, sold 162 shares of common stock.
• The sale was executed at a price of $37.651 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Werner still beneficially owns 51,272 shares of Twist Bioscience Corp.
• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations and doesn't indicate a positive or negative sentiment towards the company's prospects.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. This transaction appears routine and doesn't necessarily indicate a change in the executive's confidence in the company.

Comparison to Industry Standards

• Executive compensation practices, including equity grants and subsequent tax-related sales, are standard across publicly traded companies.
• Companies like Illumina, Inc. (ILMN) and Pacific Biosciences of California, Inc. (PACB), which operate in similar fields, also see regular Form 4 filings related to executive stock transactions.

Stakeholder Impact

• The sale of a small number of shares by an executive is unlikely to have a significant impact on shareholders.

Key Dates

Keywords

Twist Bioscience Corp, Robert F. Werner, Chief Accounting Officer, Stock Sale, Form 4, Tax Withholding, Restricted Stock Units, TWST